News Sentiment

CBUS sentiment intelligence

Cibus Global LLC news scored across direct company coverage, industry context, sector read-through, source quality, and freshness.

Chart Weekly report Factors RSS feed
Weighted score 48 Balanced news tone 58 relevant articles
Exchange NASDAQ United States
Sector Healthcare Market context
Industry Biotechnology Read-through group
Latest close 2.02 Week of 10 Jul 2026
Weighted tone 48/100

Balanced news tone

Market reaction Price moving ahead of tone

Price is moving more forcefully than the current news tone suggests.

Primary event Market update

76/100 classification confidence.

Company focus 49

directly relevant articles

Source quality 2

high-authority source matches

Trend context Trend inactive

+45.3% over one week, +64.2% over four weeks, trend inactive, and below fair value.

Latest direct headline Neutral

Cibus (CBUS) Welcomes Landmark EU Crop Breeding Decision

Market Reaction

Price moving ahead of tone

59/100 confidence

Price is moving more forcefully than the current news tone suggests.

Primary event Market update 76/100 classification
One-week reaction 45.3% Price confirming higher
Trend fit Trend inactive 64.2% over four weeks
Fair value -71.8% Below fair value
Value support

Sentiment Mix

Positive, neutral, negative

Weighted by relevance
Positive 10
Neutral 33
Negative 15

Relevance

Why the article matched

Direct first
Direct company coverage 49
Industry context 9
Sector context 0

Sources

Coverage mix

Publishers
Stock Titan 25
Market source 12
GlobeNewswire 4
simplywall.st 3
Investing.com 2
TradingView 2
Insider Monkey 1
The Globe and Mail 1

Event Lens

What the news is about

Classified themes
Market update 26
Earnings 24
Guidance 2
Balance sheet 2
Regulatory and legal 2
Analyst action 1
Deals and strategy 1

Sentiment Trail

Score over time

50 baseline
Above 50 Neutral zone Below 50

News Tape

Relevant headlines

Showing 31-58 of 58
Stock Titan Direct company coverage

Cibus (CBUS) seeks approval of directors, pay and auditor at 2026 virtual meeting

Cibus, Inc. is convening its 2026 annual virtual meeting on June 2, 2026, to address key corporate governance matters. Stockholders will vote on the election of nine directors, provide advisory approval for executive compensation, and ratify BDO USA, P.C. as the independent audit

Tone
Neutral 50/100
Event
Regulatory and legal
Published
20 Apr 2026 20:39
Source
Stock Titan
Stock Titan Direct company coverage

Cibus brings in agribusiness veteran Thomas Urban as director

Cibus Inc. (Nasdaq: CBUS) has announced the election of Thomas Urban, founder of Agribusiness Advisors, to its Board of Directors. Mr. Urban brings extensive experience in agribusiness scaling, M&A, and executive leadership from his previous roles at CellFor, Pioneer Hi-Bred, and

Tone
Positive 63/100
Event
Market update
Published
15 Apr 2026 10:39
Source
Stock Titan
Market source Direct company coverage

Cibus Announces the Election of Thomas Urban to Board of Directors

Cibus, Inc. (Nasdaq: CBUS) has announced the election of Thomas Urban to its Board of Directors. Mr. Urban brings extensive experience in agribusiness, having founded Agribusiness Advisors and previously served as CEO of CellFor, Inc. His expertise is expected to be invaluable as

Tone
Positive 73/100
Event
Market update
Published
15 Apr 2026 05:10
Source
Market source
GlobeNewswire Direct company coverage

Cibus, Inc. Investigated by the Portnoy Law Firm

The Portnoy Law Firm has initiated an investigation into Cibus, Inc. (NASDAQ: CBUS) for possible securities fraud following a 13% stock price drop. This drop was triggered by a Bonitas Research report in June 2024, alleging that Cibus's gene-editing technology lacks market eviden

Tone
Negative 19/100
Event
Regulatory and legal
Published
08 Apr 2026 09:09
Source
GlobeNewswire
Investing.com Canada Direct company coverage

Cibus announces underwritten public offering of Class A shares By Investing.com

Cibus, Inc. announced its intention to conduct an underwritten public offering of Class A common stock and pre-funded warrants. The agricultural technology company plans to use the net proceeds for working capital and general corporate purposes, including funding the development

Tone
Negative 39/100
Event
Market update
Published
27 Mar 2026 20:39
Source
Investing.com Canada
Stock Titan Direct company coverage

Cibus (NASDAQ: CBUS) sells 6.98M Class A shares at $2.15 each

Cibus, Inc. is offering 6,976,744 shares of Class A Common Stock at $2.15 per share, with an underwriter option for an additional 1,046,511 shares. The company expects to net approximately $13.5 million (or $16.0 million if the option is fully exercised) and will use the proceeds

Tone
Neutral 50/100
Event
Guidance
Published
26 Mar 2026 21:09
Source
Stock Titan
Market source Direct company coverage

Cibus, Inc. Announces Pricing of Public Offering of Class A Common Stock

Cibus, Inc. announced the pricing of a public offering of 6,976,744 shares of its Class A Common Stock at $2.15 per share, aiming to raise approximately $15 million. The company has also granted the underwriter an option to purchase an additional 1,046,511 shares. The net proceed

Tone
Neutral 50/100
Event
Market update
Published
26 Mar 2026 03:55
Source
Market source
Stock Titan Direct company coverage

Cibus (NASDAQ: CBUS) seeks capital via Class A shares and pre-funded warrants

Cibus, Inc. is offering Class A Common Stock and pre-funded warrants through a firm commitment underwritten basis to raise capital. The company, facing substantial doubt about its ability to continue as a going concern with $9.9 million cash versus $16.9 million current liabiliti

Tone
Negative 36/100
Event
Balance sheet
Published
25 Mar 2026 20:39
Source
Stock Titan
Market source Direct company coverage

Cibus, Inc. Announces Proposed Public Offering of Class A Common Stock and Pre-Funded Warrants

Cibus, Inc. (Nasdaq: CBUS) has announced its intention to offer shares of Class A common stock and pre-funded warrants in an underwritten public offering. The company also plans to grant the underwriter a 30-day option to purchase additional shares. Proceeds from the offering wil

Tone
Negative 40/100
Event
Market update
Published
25 Mar 2026 19:39
Source
Market source
Stock Titan Direct company coverage

Cibus seeks new capital for rice weed-trait work through stock sale

Cibus (Nasdaq: CBUS) announced a proposed underwritten public offering of Class A common stock and pre-funded warrants to raise capital for working capital and to fund the development of weed management traits in rice. The offering, which will be conducted under an effective Form

Tone
Negative 19/100
Event
Market update
Published
25 Mar 2026 19:39
Source
Stock Titan
Stock Titan Direct company coverage

Cibus sells nearly 7M shares to fund rice weed-trait development

Cibus (Nasdaq: CBUS) has priced an underwritten public offering of 6,976,744 Class A shares at $2.15 per share, aiming to raise approximately $15 million in gross proceeds. The company intends to use the net proceeds for working capital and to further develop its weed management

Tone
Negative 29/100
Event
Market update
Published
24 Mar 2026 22:10
Source
Stock Titan
Stock Titan Direct company coverage

Cibus (NASDAQ: CBUS) doubles down on gene-edited rice traits amid funding risk

Cibus, an agricultural biotechnology company, is intensifying its focus on gene-edited rice traits and sustainable ingredients, particularly herbicide-tolerant rice, amid ongoing funding risks. The company has streamlined operations through workforce reductions and facility conso

Tone
Neutral 50/100
Event
Market update
Published
17 Mar 2026 20:09
Source
Stock Titan
Stock Titan Direct company coverage

Gene-edited rice, $200M royalties: inside Cibus' 2027 push

Cibus (Nasdaq: CBUS) reported its Q4 2025 financial results, highlighting progress in its gene-edited Rice program with targeted commercial launches in LATAM by 2027 and the USA by 2028, potentially generating over $200 million in annual royalties. The company also announced a fi

Tone
Negative 32/100
Event
Earnings
Published
17 Mar 2026 20:09
Source
Stock Titan
Stock Titan Direct company coverage

Cibus (NASDAQ: CBUS) posts wider Q4 loss and sees cash runway into Q3 2026

Cibus, Inc. reported a wider Q4 2025 net loss of $31.9 million, driven by a $9.1 million asset impairment, despite revenue of $1.1 million and efforts to reduce operating expenses. The company's cash and cash equivalents, including recent public offering proceeds, are expected to

Tone
Negative 26/100
Event
Earnings
Published
17 Mar 2026 20:09
Source
Stock Titan
Stock Titan Direct company coverage

Cibus to detail 2025 results in March 17 earnings call event

Cibus (Nasdaq: CBUS) announced it will report its fourth quarter 2025 financial results on March 17, 2026, after the market closes. Management will host a conference call and webcast at 4:30 p.m. ET to discuss the results and provide company updates. The article also touches on t

Tone
Negative 33/100
Event
Earnings
Published
01 Mar 2026 07:40
Source
Stock Titan
Stock Titan Direct company coverage

Cibus Partnering with The John Innes Centre for UK Government’s Farming Innovation Programme Precision Breeding Initiative

Cibus (Nasdaq: CBUS) has joined the UK Government-funded LLS-ERASED precision breeding project, collaborating with the John Innes Centre and other partners. The initiative aims to develop durable resistance to Light Leaf Spot in oilseed rape, a disease that caused an estimated £3

Tone
Positive 64/100
Event
Market update
Published
06 Feb 2026 12:02
Source
Stock Titan
Stock Titan Direct company coverage

Cibus directors eye stock in planned sale to fund rice weed traits

Cibus (Nasdaq: CBUS) announced a proposed underwritten public offering of its Class A common stock to fund working capital, develop rice weed-management traits, and cover professional expenses. BTIG, LLC is the sole underwriter, with an option to purchase up to 15% additional sha

Tone
Negative 38/100
Event
Market update
Published
29 Jan 2026 14:32
Source
Stock Titan
Stock Titan Direct company coverage

Cibus board joins $20M share sale, backing rice weed trait R&D

Cibus, Inc. announced the pricing of a $20.0 million public offering of 13,333,333 shares of Class A common stock at $1.50 per share. Members of Cibus' Board of Directors have committed to purchase 1,000,000 shares in the offering. The net proceeds are intended for working capita

Tone
Negative 39/100
Event
Market update
Published
29 Jan 2026 11:59
Source
Stock Titan